Qiagen (QGEN) EBITDA (2009 - 2025)

Qiagen has disclosed EBITDA across 17 years of filings, most recently posting $50.9 million for Q4 2025.

• EBITDA for Q4 2025 came in at $50.9 million, down 3.77% year-over-year; the trailing twelve-month figure through Dec 2025 was $561.7 million (up 196.84% YoY), and the FY2025 annual result was $561.7 million, up 86.61% from the prior year.
• EBITDA came in at $50.9 million for Q4 2025 at Qiagen, down from $180.1 million in the prior quarter.
• In the past five years, EBITDA ranged from a high of $260.1 million in Q1 2022 to a low of -$175.0 million in Q2 2024.
• The 5-year median for EBITDA is $149.3 million (2024), against an average of $126.2 million.
• Across the five-year window, EBITDA tumbled 211.8% in 2024 and jumped 197.91% in 2025, its largest moves.
• Qiagen's EBITDA stood at $94.7 million in 2021, then plunged by 57.4% to $40.3 million in 2022, then climbed by 5.21% to $42.4 million in 2023, then climbed by 24.58% to $52.9 million in 2024, then dropped by 3.77% to $50.9 million in 2025.
• The last three EBITDA figures came in at $50.9 million (Q4 2025), $180.1 million (Q3 2025), and $171.4 million (Q2 2025), per Business Quant data.